New pill could regrow hair in severe alopecia – trial begins
Disease control
Not yet recruiting
This study tests a drug called deuruxolitinib in Japanese adults aged 18-65 with severe alopecia areata, an autoimmune condition causing significant scalp hair loss. Participants must have at least 50% hair loss. The trial measures how well the drug regrows hair and how satisfied…
Phase: PHASE3 • Sponsor: Sun Pharma Japan Limited • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC